Order Article Reprints

Schmidhuber S, Scheiblhofer S, Weiss R, Cserepes M, Tóvári J, Gadermaier G, Bezard E, De Giorgi F, Ichas F, Strunk D, et al. A Novel C-Type Lectin Receptor-Targeted α-Synuclein-Based Parkinson Vaccine Induces Potent Immune Responses and Therapeutic Efficacy in Mice. Vaccines. 2022; 10(9):1432. https://doi.org/10.3390/vaccines10091432

Schmidhuber, Sabine, Sandra Scheiblhofer, Richard Weiss, Mihály Cserepes, József Tóvári, Gabriele Gadermaier, Erwan Bezard, Francesca De Giorgi, François Ichas, Dirk Strunk, and et al. 2022. "A Novel C-Type Lectin Receptor-Targeted α-Synuclein-Based Parkinson Vaccine Induces Potent Immune Responses and Therapeutic Efficacy in Mice" Vaccines 10, no. 9: 1432. https://doi.org/10.3390/vaccines10091432

Schmidhuber, S., Scheiblhofer, S., Weiss, R., Cserepes, M., Tóvári, J., Gadermaier, G., Bezard, E., De Giorgi, F., Ichas, F., Strunk, D., & Mandler, M. (2022). A Novel C-Type Lectin Receptor-Targeted α-Synuclein-Based Parkinson Vaccine Induces Potent Immune Responses and Therapeutic Efficacy in Mice. Vaccines, 10(9), 1432. https://doi.org/10.3390/vaccines10091432